标普和纳斯达克内在价值 联系我们

XOMA Corporation XOMAP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
$14.46
-44.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

XOMA Corporation (XOMAP) 当前追踪市盈率 (P/E) 为 22.0, 前瞻市盈率为 23.7. 追踪盈利收益率为 4.54%, 前瞻盈利收益率 4.21%. PEG 0.82 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $14.50.

本页证实的标准:

  • VALUE (88/100, 通过) — 市盈率低于市场平均水平 (22.0); PEG ≤ 1.0 — Peter Lynch 低估标准 (0.82); 盈利收益率超过债券收益率 (4.54%).
  • PEG 比率 0.82 — 低于1.0表明股票相对于其盈利增长率被低估(Peter Lynch 标准)。
  • 追踪盈利收益率 4.54% — 与债券收益率(约4.3%)大致持平,风险回报适中。

SharesGrow 综合评分: 63/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score
63/100
SG Score
View full scorecard →
价值
88/100
Price-to-Earnings & upside
Proven by this page
~
未來
40/100
Analyst consensus
→ Forecast
过去
25/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
41/100
→ Income
成长
100/100
→ Income
收入
100/100
→ Income

估值概览 — XOMAP

估值倍数
P/E (TTM)22.0
前瞻 P/E23.7
PEG 比率0.82
前瞻 PEG0.82
P/B 比率6.23
P/S 比率8.17
EV/EBITDA33.1
每股数据
EPS (TTM)$1.63
前瞻 EPS(预估)$1.10
每股账面价值$5.75
每股营收$2.88
每股自由现金流$0.15
收益率与内在价值
盈利收益率4.54%
Forward Earnings Yield4.21%
股息收益率0.00%
格雷厄姆数$14.50
SharesGrow 内在价值$14.46 (-44.7%)

历史估值

Year P/E (TTM) PEG 比率 P/B 比率 P/S 比率 股息收益率
2016 -5.2 -0.03 -5.86 49.71 -
2017 18.9 -0.16 47.80 5.25 -
2018 -20.7 0.08 14.72 52.19 -
2019 -107.9 4.24 4.86 11.64 -
2020 20.1 -0.10 3.09 9.08 -
2021 18.8 -1.19 2.09 7.78 1.18%
2022 -16.5 0.04 2.28 46.96 1.93%
2023 -7.1 -0.07 3.29 61.26 1.88%
2024 -21.9 0.37 3.70 10.63 1.81%
2025 15.2 -0.08 4.65 9.27 1.13%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-4.72 $5.56M $-53.53M -962.1%
2017 $0.73 $52.69M $14.6M 27.7%
2018 $-1.18 $5.3M $-13.34M -251.8%
2019 $-0.88 $18.37M $-7.7M -41.9%
2020 $0.78 $29.39M $13.3M 45.3%
2021 $0.65 $38.16M $15.8M 41.4%
2022 $-1.50 $6.03M $-17.1M -283.8%
2023 $-4.04 $4.76M $-40.83M -858.2%
2024 $-0.71 $28.49M $-13.82M -48.5%
2025 $1.46 $52.15M $31.71M 60.8%

分析师预期

Year EPS(平均) EPS 范围 营收(平均) 营收范围 分析师人数
2026 $1.10 $0.63 – $1.86 $66.23M $51.7M – $92.04M 1
2027 $0.69 $0.39 – $1.16 $60.95M $35.78M – $99.77M 1
2028 $1.80 $1.03 – $3.04 $81.45M $54.53M – $124.76M 1
2029 $2.55 $1.45 – $4.30 $97.45M $65.24M – $149.26M 1
2030 $3.07 $1.75 – $5.18 $120.65M $80.77M – $184.8M 1
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言